260 related articles for article (PubMed ID: 21829638)
1. Investigation of griffithsin's interactions with human cells confirms its outstanding safety and efficacy profile as a microbicide candidate.
Kouokam JC; Huskens D; Schols D; Johannemann A; Riedell SK; Walter W; Walker JM; Matoba N; O'Keefe BR; Palmer KE
PLoS One; 2011; 6(8):e22635. PubMed ID: 21829638
[TBL] [Abstract][Full Text] [Related]
2. Scaleable manufacture of HIV-1 entry inhibitor griffithsin and validation of its safety and efficacy as a topical microbicide component.
O'Keefe BR; Vojdani F; Buffa V; Shattock RJ; Montefiori DC; Bakke J; Mirsalis J; d'Andrea AL; Hume SD; Bratcher B; Saucedo CJ; McMahon JB; Pogue GP; Palmer KE
Proc Natl Acad Sci U S A; 2009 Apr; 106(15):6099-104. PubMed ID: 19332801
[TBL] [Abstract][Full Text] [Related]
3. Griffithsin-Modified Electrospun Fibers as a Delivery Scaffold To Prevent HIV Infection.
Grooms TN; Vuong HR; Tyo KM; Malik DA; Sims LB; Whittington CP; Palmer KE; Matoba N; Steinbach-Rankins JM
Antimicrob Agents Chemother; 2016 Nov; 60(11):6518-6531. PubMed ID: 27550363
[TBL] [Abstract][Full Text] [Related]
4. Studies in a Murine Model Confirm the Safety of Griffithsin and Advocate Its Further Development as a Microbicide Targeting HIV-1 and Other Enveloped Viruses.
Kouokam JC; Lasnik AB; Palmer KE
Viruses; 2016 Nov; 8(11):. PubMed ID: 27869695
[TBL] [Abstract][Full Text] [Related]
5. Isolation and characterization of griffithsin, a novel HIV-inactivating protein, from the red alga Griffithsia sp.
Mori T; O'Keefe BR; Sowder RC; Bringans S; Gardella R; Berg S; Cochran P; Turpin JA; Buckheit RW; McMahon JB; Boyd MR
J Biol Chem; 2005 Mar; 280(10):9345-53. PubMed ID: 15613479
[TBL] [Abstract][Full Text] [Related]
6. Griffithsin, a potent HIV entry inhibitor, is an excellent candidate for anti-HIV microbicide.
Emau P; Tian B; O'keefe BR; Mori T; McMahon JB; Palmer KE; Jiang Y; Bekele G; Tsai CC
J Med Primatol; 2007 Aug; 36(4-5):244-53. PubMed ID: 17669213
[TBL] [Abstract][Full Text] [Related]
7. Griffithsin: An Antiviral Lectin with Outstanding Therapeutic Potential.
Lusvarghi S; Bewley CA
Viruses; 2016 Oct; 8(10):. PubMed ID: 27783038
[TBL] [Abstract][Full Text] [Related]
8. Griffithsin has antiviral activity against hepatitis C virus.
Meuleman P; Albecka A; Belouzard S; Vercauteren K; Verhoye L; Wychowski C; Leroux-Roels G; Palmer KE; Dubuisson J
Antimicrob Agents Chemother; 2011 Nov; 55(11):5159-67. PubMed ID: 21896910
[TBL] [Abstract][Full Text] [Related]
9. The lectins griffithsin, cyanovirin-N and scytovirin inhibit HIV-1 binding to the DC-SIGN receptor and transfer to CD4(+) cells.
Alexandre KB; Gray ES; Mufhandu H; McMahon JB; Chakauya E; O'Keefe BR; Chikwamba R; Morris L
Virology; 2012 Feb; 423(2):175-86. PubMed ID: 22209231
[TBL] [Abstract][Full Text] [Related]
10. Mannose-rich glycosylation patterns on HIV-1 subtype C gp120 and sensitivity to the lectins, Griffithsin, Cyanovirin-N and Scytovirin.
Alexandre KB; Gray ES; Lambson BE; Moore PL; Choge IA; Mlisana K; Karim SS; McMahon J; O'Keefe B; Chikwamba R; Morris L
Virology; 2010 Jun; 402(1):187-96. PubMed ID: 20392471
[TBL] [Abstract][Full Text] [Related]
11. Synergistic activity profile of griffithsin in combination with tenofovir, maraviroc and enfuvirtide against HIV-1 clade C.
Férir G; Palmer KE; Schols D
Virology; 2011 Sep; 417(2):253-8. PubMed ID: 21802104
[TBL] [Abstract][Full Text] [Related]
12. Broad-spectrum in vitro activity and in vivo efficacy of the antiviral protein griffithsin against emerging viruses of the family Coronaviridae.
O'Keefe BR; Giomarelli B; Barnard DL; Shenoy SR; Chan PK; McMahon JB; Palmer KE; Barnett BW; Meyerholz DK; Wohlford-Lenane CL; McCray PB
J Virol; 2010 Mar; 84(5):2511-21. PubMed ID: 20032190
[TBL] [Abstract][Full Text] [Related]
13. Algal lectins as potential HIV microbicide candidates.
Huskens D; Schols D
Mar Drugs; 2012 Jul; 10(7):1476-1497. PubMed ID: 22851920
[TBL] [Abstract][Full Text] [Related]
14. Activity of and effect of subcutaneous treatment with the broad-spectrum antiviral lectin griffithsin in two laboratory rodent models.
Barton C; Kouokam JC; Lasnik AB; Foreman O; Cambon A; Brock G; Montefiori DC; Vojdani F; McCormick AA; O'Keefe BR; Palmer KE
Antimicrob Agents Chemother; 2014; 58(1):120-7. PubMed ID: 24145548
[TBL] [Abstract][Full Text] [Related]
15. Rice endosperm is cost-effective for the production of recombinant griffithsin with potent activity against HIV.
Vamvaka E; Arcalis E; Ramessar K; Evans A; O'Keefe BR; Shattock RJ; Medina V; Stöger E; Christou P; Capell T
Plant Biotechnol J; 2016 Jun; 14(6):1427-37. PubMed ID: 26800650
[TBL] [Abstract][Full Text] [Related]
16. Impact of Q-Griffithsin anti-HIV microbicide gel in non-human primates: In situ analyses of epithelial and immune cell markers in rectal mucosa.
Günaydın G; Edfeldt G; Garber DA; Asghar M; Noȅl-Romas L; Burgener A; Wählby C; Wang L; Rohan LC; Guenthner P; Mitchell J; Matoba N; McNicholl JM; Palmer KE; Tjernlund A; Broliden K
Sci Rep; 2019 Dec; 9(1):18120. PubMed ID: 31792342
[TBL] [Abstract][Full Text] [Related]
17. Antiviral lectin Q-Griffithsin suppresses fungal infection in murine models of vaginal candidiasis.
Nabeta HW; Lasnik AB; Fuqua JL; Wang L; Rohan LC; Palmer KE
Front Cell Infect Microbiol; 2022; 12():976033. PubMed ID: 36329822
[TBL] [Abstract][Full Text] [Related]
18. Preformulation Characterization of Griffithsin, a Biopharmaceutical Candidate for HIV Prevention.
Kramzer LF; Hamorsky KT; Graebing PW; Wang L; Fuqua JL; Matoba N; Lasnik AB; Moncla BJ; Zhang J; Palmer KE; Rohan LC
AAPS PharmSciTech; 2021 Feb; 22(3):83. PubMed ID: 33625602
[TBL] [Abstract][Full Text] [Related]
19. Occluding the mannose moieties on human immunodeficiency virus type 1 gp120 with griffithsin improves the antibody responses to both proteins in mice.
Banerjee K; Michael E; Eggink D; van Montfort T; Lasnik AB; Palmer KE; Sanders RW; Moore JP; Klasse PJ
AIDS Res Hum Retroviruses; 2012 Feb; 28(2):206-14. PubMed ID: 21793733
[TBL] [Abstract][Full Text] [Related]
20. In vitro Study on Synergistic Interactions Between Free and Encapsulated Q-Griffithsin and Antiretrovirals Against HIV-1 Infection.
Minooei F; Fried JR; Fuqua JL; Palmer KE; Steinbach-Rankins JM
Int J Nanomedicine; 2021; 16():1189-1206. PubMed ID: 33623382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
